A Phase I Study of Cetuximab/Docetaxel(Taxotere)/Cisplatin/5-Fluorouracil (C-TPF) in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
Phase of Trial: Phase I
Latest Information Update: 10 Nov 2009
At a glance
- Drugs Cetuximab; Cisplatin; Docetaxel; Fluorouracil
- Indications Head and neck cancer
- Focus Adverse reactions
- 10 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Nov 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 17 Sep 2008 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov.